Polycystic Ovary Syndrome and Oxidative Stress-From Bench to Bedside

Zeber-Lubecka N, Ciebiera M, Hennig EE

Published September 15, 2023 International Journal of Molecular Sciences, 24(18), 14126
DOI 10.3390/ijms241814126 PMID 37762427 PMC PMC10531631

RRM Academy Synopsis

Oxidative stress and insulin resistance can fuel each other in PCOS

A 2023 review of lab and clinical studies says oxidative stress and insulin resistance can feed each other in polycystic ovary syndrome (PCOS). Extra androgens and faulty mitochondria may add to the loop, and the authors discuss antioxidants as possible treatments.

Key Findings

  • The review cites World Health Organization data putting PCOS prevalence at 8% to 13%, varying with the population studied.
  • Of women with PCOS, 80% of those with obesity and 30–40% of lean women have reduced insulin sensitivity, the review states.
  • Roughly 5% to 10% of women have hyperandrogenemia, and PCOS is the main cause, accounting for about 80% of cases.
  • A meta-analysis of 18 studies with 2185 participants found N-acetylcysteine may lower total testosterone and raise FSH in PCOS. Follicle number, LH and SHBG showed no significant change.
  • The 2023 guideline reviewed 29 randomized trials of inositol and found moderate certainty for menstrual cycle regulation and very low certainty for metabolic and hormonal benefits.

Interpretation

The article is a review that briefly discusses lab, animal and human studies on PCOS, also called PMOS (Polyendocrine Metabolic Ovarian Syndrome). Several mechanisms come from mouse and cell experiments. The authors state that mitochondrial mutations are not widely recognized as the primary cause of PCOS. They call antioxidants promising and say dosage and effectiveness remain under study.

RRM Context

Restorative reproductive medicine looks for the root causes of PCOS. The review proposes links among insulin resistance, androgen excess and mitochondria. Its ovulation section calls reactive oxygen species part of normal ovulation signals, and harmful in excess. The authors cite exercise and diet as ways shown to reduce oxidative stress.

Abstract

Oxidative stress (OS) is a condition that occurs as a result of an imbalance between the production of reactive oxygen species (ROS) and the body's ability to detoxify and neutralize them. It can play a role in a variety of reproductive system conditions, including polycystic ovary syndrome (PCOS), endometriosis, preeclampsia, and infertility. In this review, we briefly discuss the links between oxidative stress and PCOS. Mitochondrial mutations may lead to impaired oxidative phosphorylation (OXPHOS), decreased adenosine triphosphate (ATP) production, and an increased production of ROS. These functional consequences may contribute to the metabolic and hormonal dysregulation observed in PCOS. Studies have shown that OS negatively affects ovarian follicles and disrupts normal follicular development and maturation. Excessive ROS may damage oocytes and granulosa cells within the follicles, impairing their quality and compromising fertility. Impaired OXPHOS and mitochondrial dysfunction may contribute to insulin resistance (IR) by disrupting insulin signaling pathways and impairing glucose metabolism. Due to dysfunctional OXPHOS, reduced ATP production, may hinder insulin-stimulated glucose uptake, leading to IR. Hyperandrogenism promotes inflammation and IR, both of which can increase the production of ROS and lead to OS. A detrimental feedback loop ensues as IR escalates, causing elevated insulin levels that exacerbate OS. Exploring the relations between OS and PCOS is crucial to fully understand the role of OS in the pathophysiology of PCOS and to develop effective treatment strategies to improve the quality of life of women affected by this condition. The role of antioxidants as potential therapies is also discussed.

By this author

Related research

Natalia Zeber-Lubecka, Michał Ciebiera, Ewa E Hennig
N Zeber-Lubecka, M Ciebiera, E Hennig
PMID 37762427 37762427 DOI 10.3390/ijms241814126 10.3390/ijms241814126 Zeber-Lubecka et al. 2023, Zeber-Lubecka 2023